Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vyznova by Aurion Biotechnologies for Corneal Edema: Likelihood of Approval
Vyznova is under clinical development by Aurion Biotechnologies and currently in Phase II for Corneal Edema. According to GlobalData, Phase...
Data Insights
Vyznova by Aurion Biotechnologies for Corneal Edema: Likelihood of Approval
Vyznova is under clinical development by Aurion Biotechnologies and currently in Phase II for Corneal Edema. According to GlobalData, Phase...